TRCT
PROK icon

Tower Research Capital (TRC)’s ProKidney PROK Stock Holding History

Tower Research Capital (TRC)’s Portfolio PROK Stock Details PROK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$9.84K Sell
4,822
-15,617
-76% -$28.6K ﹤0.01% 4005
2026
Q1 		$36.6K Buy
20,439
+20,424
+136,160% +$43.3K ﹤0.01% 3012
2025
Q4 		$34 Sell
15
-4,176
-100% -$11K ﹤0.01% 5085
2025
Q3 		$10.1K Sell
4,191
-51,211
-92% -$136K ﹤0.01% 3995
2025
Q2 		$32.8K Buy
55,402
+39,649
+252% +$30.9K ﹤0.01% 3333
2025
Q1 		$13.8K Buy
15,753
+4,996
+46% +$6.93K ﹤0.01% 3332
2024
Q4 		$18.2K Buy
10,757
+5,658
+111% +$10.2K ﹤0.01% 3267
2024
Q3 		$9.79K Sell
5,099
-7,915
-61% -$18K ﹤0.01% 3833
2024
Q2 		$32K Sell
13,014
-1,144
-8% -$3.07K ﹤0.01% 3433
2024
Q1 		$23.2K Buy
14,158
+1,913
+16% +$2.81K ﹤0.01% 2870
2023
Q4 		$21.8K Buy
12,245
+4,890
+66% +$10.5K ﹤0.01% 3591
2023
Q3 		$33.7K Buy
7,355
+4,891
+198% +$46.8K ﹤0.01% 2919
2023
Q2 		$27.6K Sell
2,464
-1,992
-45% -$21.2K ﹤0.01% 3102
2023
Q1 		$50K Buy
4,456
+2,211
+98% +$23.5K ﹤0.01% 2498
2022
Q4 		$15K Buy
2,245
+1,160
+107% +$11.1K ﹤0.01% 3444
2022
Q3 		$10K Buy
1,085
+432
+66% +$3.76K ﹤0.01% 4565
2022
Q2 		$6K Buy
+653
New +$6.46K ﹤0.01% 4945
2022
Q1 		– Sell
-536
Closed -$5K – 6458
2021
Q4 		$5K Buy
+536
New +$5.3K ﹤0.01% 5184

Other funds holding PROK

SCM
Suvretta Capital Management New York $5.47B AUM 131.34% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
BL
Bleichroeder LP New York $559M AUM 83.7% 1-Year Est. Return
HWAM
Hennion & Walsh Asset Management Parsippany, New Jersey $3.5B AUM 41.95% 1-Year Est. Return
AGP
Artia Global Partners Miami, Florida $542M AUM 206.64% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

Tower Research Capital (TRC)'s PROK Position: Q2 2026 in Review

Tower Research Capital (TRC) reduced its ProKidney (PROK) stake by 76% in Q2 2026, selling an estimated $28.6K and leaving 4,822 shares worth $9.84K. The position accounts for ﹤0.01% of the portfolio, ranked #4005.

Tower Research Capital (TRC) first reported a position in PROK in Q4 2021 and has held it in 18 quarters since. The position peaked at $50K in Q1 2023. 71 funds tracked by Wall St. Rank hold PROK as of Q2 2026.

  • Tower Research Capital (TRC) held 4,822 shares of ProKidney worth $9.84K as of Q2 2026.
  • Tower Research Capital (TRC) sold 15,617 ProKidney shares in Q2 2026, an estimated $28.6K.
  • ProKidney made up ﹤0.01% of Tower Research Capital (TRC)'s portfolio in Q2 2026, its #4005 holding.
  • Tower Research Capital (TRC) first reported a position in ProKidney in Q4 2021 and has held it in 18 quarters since.
  • Tower Research Capital (TRC)'s ProKidney position peaked at $50K in Q1 2023.
  • 71 funds tracked by Wall St. Rank held ProKidney as of Q2 2026.

Based on Tower Research Capital (TRC)'s 13F filing for Q2 2026, filed 11 Aug 2026.